Search clinical trials for: HFA MDI

Total 469 results

Guangdong Provincial People's Hospital

Unknown

Insulin Pump Therapy and Continuous Glucose Monitoring in Diabetic Continuous Ambulatory Peritoneal Dialysis (CAPD) Patients

Diabetes | Poor Glycemic Control

China
Research in Real-Life Ltd
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Device Mixing in Asthma, a General Practice Research Database Study (EBsalbutamol)

Asthma

United Kingdom
Research in Real-Life Ltd
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Real-life Effectiveness and Cost-effectiveness of Qvar Versus FP and BDP in the Management of COPD (QvarCOPD)

Chronic Obstructive Pulmonary Disease

United Kingdom
AstraZeneca

Completed

Titratable Dosing in Moderate to Severe Asthmatics

Asthma
AstraZeneca

Completed

A Two-week Study Assessing the Onset of Effect Questionnaire (OEQ) Administered Daily Versus Weekly in Adult Subjects

Asthma

United States
AstraZeneca

Completed

A Two-week Study Assessing the Onset of Effect Questionnaire Administered Pre-dose Versus Post-dose in Adult Subjects

Asthma

United States
SkyePharma AG
Abbott

Completed

Single-dose Crossover Study to Evaluate the Early Bronchodilating Effect of FlutiForm HFA pMDI in Adult Subjects With Mild to Moderate Asthma

Mild to Moderate Asthma

United States
SkyePharma AG
Abbott; MDS Pharma Services

Completed

A Study Comparing the Safety and Efficacy of Fluticasone and Formoterol Combination (FlutiForm™) With Fluticasone or Flovent to Treat Moderate to Severe Asthma in Adolescents and Adults

Asthma

United States, Chile, Mexico, Peru, Romania, Hungary, South Africa, Ukraine, Poland, Argentina
Taiwan Otsuka Pharm. Co., Ltd

Completed

A Study to Evaluate the Efficacy and Safety of Meptin® Swinghaler® and Ventolin® MDI in Stable Asthma Patients

Asthma

Taiwan
Research in Real-Life Ltd
Mundipharma Research Limited

Completed

Real-world Effectiveness of Combination Therapy in Asthma

Asthma

United Kingdom
DexCom, Inc.

Completed

Efficacy of Continuous Glucose Monitoring in Subjects With Type 1 Diabetes Mellitus on Multiple Daily Injections (MDI) or Continuous Subcutaneous Insulin Infusion (CSII) Therapy

Type 1 Diabetes Mellitus

United States
AstraZeneca

Completed

Lung Deposition Via Different Inhalation Devices

Healthy Volunteers

Sweden
Sanofi

Completed

Insulin Glargine Plus Insulin Glulisine Multiple Daily Injections (MDI) Versus Premix Insulin Treatment in Subjects With Diabetes Mellitus (Type 1 or Type 2)

Diabetes Mellitus

United States
University of Saskatchewan
Royal University Hospital Foundation

Completed

Duration of Protective Effect From Inhaled Ipratropium Bromide on Methacholine Airway Hyperresponsiveness

Asthma

Canada
Medical Research Foundation, The Netherlands
Medtronic

Completed

Study to Compare Intraperitoneal Insulin to Subcutaneous Insulin Administration in Type 1 Diabetes Mellitus

Diabetes Mellitus, Type 1

Netherlands
Mackay Memorial Hospital

Completed

Bronchodilatation Effects of a Small Volume Spacer Used With a Metered-Dose Inhaler (MDI)

Asthma

Taiwan
Bayside Health

Unknown

Can a Modified Fat Diet With Low Glycaemic Load Improve Insulin Sensitivity and Inflammatory Mediators in Overweight People With Chronic Heart Failure?

Heart Failure

Australia
Maastricht University Medical Center
AstraZeneca; Teva Branded

Completed

The Anti-Inflammatory Effect of Extrafine HFA-Beclometasone Versus HFA-Fluticasone, by Means of Inflammometry

Asthma

Netherlands
Sanofi
Takeda

Completed

Effects of Ciclesonide MDI 50mg/Day and 200mg/Day (Ex-Valve) Once-Daily on Growth in Children With Mild Persistent Asthma

Asthma

3

Subscribe